The next step for your CGM business
continuous glucose monitors
Dexcom announced the G6 model of its CGM system will no longer be available beginning July 1, 2026
SAN DIEGO—Dexcom, a manufacturer of continuous glucose monitoring (CGM) sensors, announced that it will stop producing the G6 model of their CGM system starting July 1, 2026.
While supplies may be available through local pharmacies or local medical distributors for a while afterwards, Dexcom said it cannot guarantee availability of the G6 after July 1 and is encouraging everyone who uses the G6 to work with their doctor to upgrade to the G7 as soon as they can.
The Centers for Medicare & Medicaid Services updated its fact sheet on the recent final rule that includes competitive bidding for durable medical equipment, confirming that many products will not be included
WASHINGTON—A wide range of durable medical equipment (DME), including oxygen, mobility and CPAP products, will not be included in the upcoming round of the competitive bidding program, according to an update from the Centers for Medicare & Medicaid Services (CMS).
The Deptartment of Health and Human Services Office of Inspector General published a report that found Medicare overpayments for CGMs
The Dept. of Health and Human Services Office of Inspector General (OIG) published a report on continuous glucose monitors (CGMs) and supplies acquisition cost. In the report, "Medicare Payments for Continuous Glucose Monitors and Supplies Exceeded Supplier Costs and Retail Market Prices, Indicating Medicare Can Save At Least Tens of Millions of Dollars in One Year," the OIG recommends that the Centers for Medicare & Medicaid Services (CMS) seek payment reductions for CGMs and supplies.
The new Dexcom G7 15 Day Continuous Glucose Monitoring System officially launched on Dec. 1
SAN DIEGO—DexCom, Inc., a medical device company that manufactures continuous glucose monitoring systems (CGMs) for diabetes management, announced the official launch of the DexCom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes in the United States on Monday, Dec. 1.
AdvaMed said it supports a letter penned by senators to Centers for Medicare & Medicaid Services advocating to keep diabetes management products out of competitive bidding
WASHINGTON—AdvaMed, a trade association representing medical technology companies, praised a letter to Centers for Medicare and Medicaid Services (CMS) Administrator Mehmet Oz urging the agency not to finalize a proposal the lawmakers warned could reduce and complicate patient access to continuous glucose monitors (CGMs) and durable insulin pumps.
AAHomecare said these resources are designed to support conversations with referral sources & certified diabetes educators
ARLINGTON, Virginia—American Association for Homecare announced it has developed new resources to help diabetes-focused durable medical equipment (DME) suppliers demonstrate the value of prescribing continuous glucose monitors (CGM) through the DME channel.
AAHomecare said these resources are designed to support conversations with referral sources and certified diabetes educators, reinforcing the role of DME suppliers in improving access, support and adherence.
Why CGMs are the new standard in diabetes care—& an unmissable opportunity for providers
Certain Dexcom G6, G7, ONE & ONE+ will be removed due to speaker malfunctions
SAN DIEGO—Dexcom, Inc. is recalling certain Dexcom G6, G7, ONE and ONE+ glucose monitoring receivers because a problem with the speaker may cause it to fail to make an alert sound when blood sugar is dangerously low or high.
The use of affected product may cause serious adverse health consequences, including seizures, vomiting, loss of consciousness and death.
There have been at least 56 reported injuries. There have been no reports of death.
The company’s new virtual diabetes program, Eddii-Care for Adults, aims to expand accessibility to diabetes care
NEW YORK—Eddii, a health technology company that focuses on diabetes management solutions, announced the launch of its new virtual diabetes care platform, eddii-Care for Adults. The platform, which is for adults living with type one or type two diabetes, has launched in eight states: California, Illinois, Maryland, New Jersey, New York, Oregon, Texas and Washington.
The partnership intends to promote metabolic health management experience by enabling two-way data flow between Dexcom glucose biosensors & the Ōura Ring
SAN DIEGO & SAN FRANCISCO—Dexcom Inc., a glucose biosensing technology company, and Ōura, a personalized health data company and creator of the sleep- and health-tracking Ōura Ring, announced a partnership that aims to improve customers’ metabolic health through the integration of Dexcom’s glucose data with the health data provided by the Ōura Ring.
The acquisition aims to enhance home delivery options for patients with specialized health care needs
MELVILLE, New York—Henry Schein Inc., a provider of health care solutions to office-based dental and medical practitioners, announced it will acquire Acentus, a national medical supplier specializing in the delivery of continuous glucose monitors (CGM).
ASHEVILLE, N.C., (September 29, 2022)—Aeroflow Healthcare, a national provider of consumer-driven health care products and services, announced a contract with UCare, an independent, nonprofit health plan providing health coverage and services across Minnesota and western Wisconsin.